TRADE AND EXECUTIVE CHANGES IN OTC DRUG BUSINESS
This article was originally published in The Tan Sheet
Executive Summary
TRADE AND EXECUTIVE CHANGES IN OTC DRUG BUSINESS are affecting the way the Nonprescription Drug Manufacturers Association perceives its relationship to its membership and its functions, the association management indicated in presentations at the May 15-16 annual meeting. "To meet a growing need" related to executive changes in the OTC industry, NDMA Chairman David Collins (Schering-Plough) said, the association will "soon begin a series of training seminars for personnel new to a company or new to the issues of the industry."